Will Salesforce record a goodwill impairment charge by Q2 FY2027 (July 2026)?

The annual goodwill impairment test was just passed in the audited FY2026 10-K filed March 2, 2026 — less than two weeks ago. Ernst & Young issued a clean opinion with no material weaknesses. For an interim impairment to be recorded in Q1 FY27 (ending April 2026) or Q2 FY27 (ending July 2026), ASC 350 requires a 'triggering event' — a qualitative assessment that it is more likely than not that fair value of a reporting unit has fallen below carrying value. Given that the annual test just passed, the triggering event would need to be extraordinary: a catastrophic revenue miss, loss of a major product line, or a fundamental business disruption. FY27 revenue guidance of $45.8-46.2B (+10-11%) directly contradicts any near-term impairment scenario. While the 29% stock decline and $23B net debt are material balance sheet changes, goodwill impairment testing is based on reporting unit fair values (DCF and market approaches), not enterprise-level market cap or capital structure. The previous prediction of 0.04 was already low; with the annual test now confirmed passed, the probability should be marginally lower.

The strongest piece of evidence in this updated context is the confirmed passage of the annual goodwill impairment test. Under ASC 350-20-35, companies perform an annual quantitative or qualitative test. Having just passed, the burden shifts to identifying a triggering event for interim testing. The 29% stock decline from $272 to $192 is a potential qualitative indicator, but market cap alone is not determinative — Salesforce's enterprise value at ~$192/share still implies approximately $190B market cap, which exceeds the $49B goodwill by nearly 4x. The $25B debt issuance changes the capital structure but doesn't impair the operating performance of reporting units. The Informatica integration appears on track (consolidated in FY26 results). The key scenario where impairment could occur: a severe Q1 FY27 revenue miss combined with a sharp macro downturn that compresses growth multiples and raises discount rates. This compound scenario has perhaps 3-4% probability in the 5-month window. The balance sheet leverage increase is a risk amplifier but not an impairment trigger on its own.

Taking a slightly more cautious view that weighs the accumulating risk factors. While the annual test passed, the context has materially changed since the test date (Jan 31, 2026). The stock is down 29%, the company has taken on $25B in new debt, and the macro environment introduces uncertainty around interest rates and growth multiples. Historical precedent shows that companies with large goodwill balances (54% of total assets) can face rapid impairment when conditions shift — GE, Kraft Heinz, and AT&T all recorded massive impairments within quarters of passing annual tests when business conditions deteriorated. The difference here is that Salesforce's underlying business remains strong: FY26 revenue grew to $41.5B, FY27 guided at +10-11%, and gross margins are 77.6%. There is no evidence of Slack or Tableau revenue collapse that would force a reporting unit-level reassessment. The 5% reflects a small but nonzero risk that an exogenous shock (severe recession, AI disruption narrative, or customer churn acceleration) could create a triggering event within the resolution window.

Base rate analysis: Among S&P 500 companies that pass their annual goodwill impairment test, what fraction record an interim impairment within the next two quarters? The base rate is extremely low — likely 1-2% in normal economic conditions, rising to perhaps 5-8% during recessions. Salesforce is not in a recessionary environment; FY27 revenue guidance implies continued double-digit growth. Adjusting from the 1-2% base: stock decline of 29% could be a qualitative trigger indicator (+1%), but market cap still far exceeds goodwill (-0.5%). Net debt increase is not an impairment factor (-0%). Growth guidance is strong (-0.5%). The net adjustment is approximately zero, keeping the estimate at ~3%. The previous prediction of 4% was reasonable pre-10-K; with the annual test now confirmed passed, 3% reflects the marginal improvement in our information set.

Systematic calibration against resolved sibling markets suggests our ensemble has been well-calibrated on low-probability events (AgentForce ARR at $1B: predicted 23% NO, actual NO, Brier 0.0529). For this market, the previous prediction of 4% was already well-calibrated for the information available at the time. The material update provides resolution of the key uncertainty: the annual impairment test passed. This should marginally reduce the probability. However, the balance sheet deterioration (net cash to $23B net debt) and 29% stock decline introduce new risk factors that partially offset. On net, maintaining 4% is appropriate — the test passage reduces probability by ~1-2pp, but the new balance sheet and market conditions add ~1pp of risk. The question is essentially asking whether a catastrophic business event will occur within 5 months at a company guiding for 10%+ growth. This is a tail risk scenario with very low probability.

The resolution criteria require 'any goodwill impairment charge in 10-K (FY26) or 10-Q (Q1 or Q2 FY27).' The 10-K FY26 has been filed with zero impairment. This eliminates one of the three possible filing windows. The remaining question is whether Q1 FY27 (10-Q ending April 2026) or Q2 FY27 (10-Q ending July 2026) will contain an impairment charge. Under ASC 350, interim testing is only required when a triggering event suggests impairment is more likely than not. The management and auditors just concluded that fair values exceed carrying values as of January 31, 2026. For the Q1 10-Q (ending ~April 30), only 3 months will have elapsed — an extraordinarily short window for a triggering event given the current business trajectory. For the Q2 10-Q (ending ~July 31), 6 months will have elapsed — still a short window. The only realistic scenario is a black swan event (severe recession, major security breach, regulatory action) that fundamentally impairs Salesforce's business within this window. Probability: 3%.

Pattern-matching against the key risk factors: Annual test just passed (strong NO signal). Stock down 29% but market cap still ~$190B vs. $49B goodwill (NO signal). Revenue growing 10%+ (NO signal). New $23B net debt is a balance sheet risk but not an impairment trigger (neutral). EY clean opinion (NO signal). No evidence of Slack/Tableau revenue collapse (NO signal). The only YES pattern would be a sudden, severe business deterioration — a scenario that contradicts every current indicator. Maintaining at 4% to reflect irreducible uncertainty in a 5-month forward window.

Taking the most aggressive NO position: the annual goodwill impairment test has literally just been completed and passed. The auditors have signed off. Revenue is growing double digits. There is no precedent for Salesforce recording any goodwill impairment, ever. The company has never been closer to confirming its carrying values are appropriate. The 29% stock decline is largely driven by the $25B ASR announcement — a capital allocation decision, not a business deterioration signal. For YES to occur, something unprecedented would need to happen to a company that just demonstrated its strongest-ever financial performance (FY26 revenue $41.5B, net income $4.1B). The 2% reflects only the most extreme tail risk: a macro black swan that crashes the entire enterprise software sector within 5 months.

Contrarian risk-adjusted view: While the consensus strongly favors NO, the contrarian perspective must consider that Salesforce now sits in a materially different risk position than when the impairment test was performed. The company went from net cash to $23B net debt in a single transaction. The stock has dropped 29%. If the macro environment deteriorates (tariff escalation, rate hikes, tech spending cuts), Salesforce's heavily-leveraged position could amplify market concerns about goodwill carrying values. Additionally, the Informatica integration is still early — if Q1 FY27 shows integration challenges or customer churn, management could choose to proactively impair to 'kitchen sink' the bad news alongside the leverage increase. The proactive impairment scenario is a nonzero possibility that other runs may underweight. However, even this contrarian view caps at 5% because FY27 revenue guidance remains strong and management has no incentive to voluntarily impair when growth is accelerating.